Clinical Trial

A Comparison of Remimazolam Besylate and Propofol Sedation in Patients Undergoing Colonoscopic Polypectomy

Study acronym: Bypro
Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The goal of this prospective, randomized, controlled study is to compare remimazolam besilat/sufentanyl and propofol/sufentanyl in patients during colonoscopic polypectomies procedures. Patients undergoing colonoscopic polypectomies in procedural sedation using remimazolam besylate/sufentanyl are circulatory and respiratory as or more stable when compared with propofol/sufentanyl sedation.
Trial Details
NCT Number NCT07456111
Lead Sponsor Clinical Hospital Centre Zagreb
Conditions Colonic Polyp, Sedation Complication
Enrollment 90 participants
Start Date 2025-01-01
Primary Completion 2027-11-30 (estimated)
Study Completion 2028-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-06